Table 1.
Incidence of insulin use after the diagnosis of different types of diabetes in national databases
| Type of diabetes | Setting | Insulin use at 1 year | Insulin use at 5 years | ||||
|---|---|---|---|---|---|---|---|
| Incidence | Unadjusted odds/hazard ratio | Adjusted* odds/hazard ratio | Incidence | Unadjusted odds/hazard ratio | Adjusted* odds/hazard ratio | ||
| Type 2 diabetes | UK | 1.4% | 1.0 | 1.0 | 4.1% | 1.0 | 1.0 |
| Type 2 diabetes | South Korea | 10.8% | 1.0 | 1.0 | 19.3% | 1.0 | 1.0 |
| DEP overall | UK | 16.3% | 13.5 (10.3–17.5) | 9.6 (7.0–13.2) | 29.6% | 9.9 (7.2–13.4) | 7.4 (5.2–10.4) |
| DEP overall | South Korea | 17.8% | 1.71 (1.58–1.85) | 1.39 (1.29–1.51) | 32.4% | 1.63 (1.54–1.73) | 1.38 (1.30–1.47) |
| PPDM-A | UK | 9.7% | 7.5 (5.0–10.9) | 6.4 (4.1–9.7) | 20.9% | 6.2 (4.0–9.3) | 5.2 (3.3–8.2) |
| DEP other than PPDM-A | UK | 28.9% | 28.3 (19.6–40.2) | 16.4 (10.4–25.6) | 45.8% | 19.8 (12.3–31.7) | 12.9 (7.4–22.2) |
*The UK study adjusted for age, sex, ethnicity, index of multiple deprivation score, smoking status, and BMI. The South Korean study adjusted for age, sex, BMI, fasting plasma glucose, LDL cholesterol, alcohol consumption, smoking status, medical coverage, systolic blood pressure, triglycerides, eGFR, and Charlson comorbidity index
BMI body mass index, eGFR estimated glomerular filtration rate, DEP diabetes of the exocrine pancreas, LDL low-density lipoprotein, PPDM-A, post-pancreatitis diabetes mellitus including diabetes after acute pancreatitis